- Home
- TRVI vs LVWR Comparison
TRVI vs LVWR Comparison
Compare TRVI & LVWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- LVWR
- Stock Information
- Founded
- TRVI 2011
- LVWR 2022
- Country
- TRVI United States
- LVWR United States
- Employees
- TRVI N/A
- LVWR N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- LVWR
- Sector
- TRVI Health Care
- LVWR
- Exchange
- TRVI Nasdaq
- LVWR Nasdaq
- Market Cap
- TRVI 383.4M
- LVWR N/A
- IPO Year
- TRVI 2019
- LVWR N/A
- Fundamental
- Price
- TRVI $6.50
- LVWR $2.13
- Analyst Decision
- TRVI Strong Buy
- LVWR Hold
- Analyst Count
- TRVI 8
- LVWR 1
- Target Price
- TRVI $17.56
- LVWR $7.25
- AVG Volume (30 Days)
- TRVI 4.4M
- LVWR 28.5K
- Earning Date
- TRVI 03-18-2025
- LVWR 04-24-2025
- Dividend Yield
- TRVI N/A
- LVWR N/A
- EPS Growth
- TRVI N/A
- LVWR N/A
- EPS
- TRVI N/A
- LVWR N/A
- Revenue
- TRVI N/A
- LVWR $26,633,000.00
- Revenue This Year
- TRVI N/A
- LVWR $249.13
- Revenue Next Year
- TRVI N/A
- LVWR $98.53
- P/E Ratio
- TRVI N/A
- LVWR N/A
- Revenue Growth
- TRVI N/A
- LVWR N/A
- 52 Week Low
- TRVI $2.30
- LVWR $1.90
- 52 Week High
- TRVI $7.39
- LVWR $9.00
- Technical
- Relative Strength Index (RSI)
- TRVI 66.37
- LVWR 44.11
- Support Level
- TRVI $6.22
- LVWR $1.95
- Resistance Level
- TRVI $6.79
- LVWR $2.11
- Average True Range (ATR)
- TRVI 0.40
- LVWR 0.15
- MACD
- TRVI -0.03
- LVWR 0.05
- Stochastic Oscillator
- TRVI 52.24
- LVWR 45.45
Stock Price Comparison Chart: TRVI vs LVWR
■ TRVI
■ LVWR
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
Share on Social Networks:
0